Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuromodulation in bladder dysfunction

S T Hasan1, D E Neal

  • 1Department of Urology, Sunderland Royal Hospital, UK.

Current Opinion in Obstetrics & Gynecology
|November 18, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Men's experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study.

Cancer causes & control : CCC·2021
Same author

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.

Scientific reports·2017
Same author

Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].

EBioMedicine·2017
Same author

Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries.

European journal of clinical nutrition·2017
Same author

Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries.

European journal of clinical nutrition·2016
Same author

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

The New England journal of medicine·2016
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Neuromodulation offers symptom relief for lower urinary tract disorders like urgency and incontinence. While mechanisms are unclear and placebo effects may play a role, it

Area of Science:

  • Urology
  • Neurology

Background:

  • Lower urinary tract disorders (LUTDs) encompass a range of conditions affecting bladder function.
  • Neuromodulation presents a therapeutic option for managing both neuropathic and non-neuropathic bladder dysfunctions.

Purpose of the Study:

  • To evaluate neuromodulation as a management strategy for diverse lower urinary tract disorders.
  • To assess the efficacy and characteristics of neuromodulation in treating conditions such as urgency and urge incontinence.

Main Methods:

  • Review of existing literature and clinical data on neuromodulation techniques for LUTDs.
  • Analysis of reported urodynamic changes and symptomatic improvements associated with neuromodulation.

Main Results:

  • Neuromodulation commonly leads to symptomatic improvements in patients with LUTDs.

Related Experiment Videos

  • Urodynamic changes associated with neuromodulation are generally minimal.
  • The precise mechanisms of action for neuromodulation in LUTDs require further elucidation.

    • Conclusions:

    • Neuromodulation is a valuable addition to the treatment options for lower urinary tract dysfunctions.
    • While generally safe with fewer side effects than surgical options, the potential impact of the placebo effect warrants consideration.
    • Further research is needed to clarify cost-effectiveness and optimize neuromodulation strategies.